Literature DB >> 4162323

Acetylsalicylic acid as a cause of pancytopenia from bone-marrow damage.

L Wijnja, J A Snijder, H O Nieweg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4162323     DOI: 10.1016/s0140-6736(66)90363-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  [Not Available].

Authors:  J M Delage
Journal:  Can Fam Physician       Date:  1968-01       Impact factor: 3.275

2.  Fatal aplastic anemia following indomethacin ingestion.

Authors:  E Menkes; G J Kutas
Journal:  Can Med Assoc J       Date:  1977-07-23       Impact factor: 8.262

Review 3.  Platelet function: a review. II. Abnormal function.

Authors:  S Berger
Journal:  Can Med Assoc J       Date:  1970-06-20       Impact factor: 8.262

4.  Analgesic habits of 500 veterans: incidence and complications of abuse.

Authors:  M H Gault; T C Rudwal; N I Redmond
Journal:  Can Med Assoc J       Date:  1968-03-30       Impact factor: 8.262

Review 5.  Platelets, aspirin, and cardiovascular disease.

Authors:  P C Elwood; C Hughes; J R O'Brien
Journal:  Postgrad Med J       Date:  1998-10       Impact factor: 2.401

Review 6.  Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics.

Authors:  L F Prescott
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

7.  [Prevention of thrombosis using aspirin? nfluence of acetylsalicylic acid on thrombocyte aggregation in vitro and in vivo].

Authors:  I Scharrer; M Schepping; K Breddin
Journal:  Klin Wochenschr       Date:  1969-12-15

Review 8.  Haematological effects of non-narcotic analgesics.

Authors:  P A Miescher; W Pola
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Phenacetin-induced haemolytic anaemia.

Authors:  R J Davidson
Journal:  J Clin Pathol       Date:  1971-09       Impact factor: 3.411

Review 10.  New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism.

Authors:  Ymer H Mekaj; Fetije T Daci; Agon Y Mekaj
Journal:  Ther Clin Risk Manag       Date:  2015-09-24       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.